METTL14 and esophageal squamous cell carcinoma: Similarly, METTL14 was shown to enhance the expression of miR-99a-5p, which inhibits the persistence of cancer stem-like cells (CSCs) and reduces the radioresistance of esophageal squamous cell carcinoma (ESCC).